Patent · US Active

Multi-specific binding proteins and methods of use thereof

US12404328B2 · kind B2 · utility

0Cited by

0References

26Claims

0Family size

Assignee

Cullinan Management, Inc. · US

Inventors

Patrick Baeuerle · Gauting, DE
Jennifer Michaelson · Cambridge, US
Bochong Li · Boston, US
Naveen Mehta · Cambridge, US

Key dates

Filing date	Jun 7, 2019
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Feb 14, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to multi-specific binding proteins that bind CD19, CD3, and serum albumin. The invention also relates to pharmaceutical compositions comprising these multi-specific binding proteins, expression vectors and host cells for making these multi-specific binding proteins, and methods of use of these multi-specific binding proteins in treating hematologic cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.